Enzyme-Prodrug Strategies For Cancer Therapy by Roger G. MeltonEnzyme-Prodrug Strategies For Cancer Therapy by Roger G. Melton

Enzyme-Prodrug Strategies For Cancer Therapy

EditorRoger G. Melton, Richard J. Knox

Hardcover | January 31, 1999

Pricing and Purchase Info


Earn 1,490 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Antibody-directed enzyme prodrug therapy (ADEPT) directly addresses the major problem in cancer chemotherapy-its lack of selectivity. Antibody delivery combined with the amplification provided by the enzymatic activation of prodrugs enables selection to be made between tumour and normal tissue. ADEPT offers a novel field of opportunities in the therapy of systemic cancer and may be a major advance for the treatment of solid tumours. This book is the first to describe ADEPT in detail. Each chapter reviews an aspect of the immunology, enzymology, biochemistry, chemistry, and cancer chemotherapy which have been integrated into the ADEPT concept. An additional chapter describes the related approach of gene-directed enzyme prodrug therapy (GDEPT). This latter approach is still in its infancy but ADEPT has entered the clinic. The initial clinical studies with ADEPT are included and discussed in detail.
Title:Enzyme-Prodrug Strategies For Cancer TherapyFormat:HardcoverDimensions:270 pages, 9.25 × 6.1 × 0 inPublished:January 31, 1999Publisher:Springer USLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0306458950

ISBN - 13:9780306458958

Look for similar items by category:


Table of Contents

Introduction; R.J. Knox, R.G. Melton. Prodrugs in Cancer Chemotherapy; T. Connors. Factors Influencing Tumor-Selective Localization of Antibody Conjugates; M.A. Sims, R.G. Melton. Enzymes and Prodrugs Used for ADEPT; R.J. Knox. The Design and Synthesis of Prodrugs for Antibody-Directed Enzyme Prodrug Therapy (ADEPT); P.J. Burke. Preparation and Purification of Antibody-Enzyme Conjugates for Therapeutic Applications; R.G. Melton. Phage Technology for Producing Antibody-Enzyme Fusion Proteins; K.A. Chester, et al. Early Clinical Studies with ADEPT; K.D. Bagshawe, M. Napier. Gene-Directed Enzyme Prodrug Therapy (GDEPT) of Cancer; R.J. Knox. Appendix: Enzymes and Prodrugs Proposed for Cancer Therapy. References. Index.